|
HS Code |
484702 |
| Cas Number | 1004-72-6 |
| Molecular Formula | C4H5N3O2 |
| Molecular Weight | 127.10 g/mol |
| Iupac Name | 6-aminopyrimidine-2,4(1H,3H)-dione |
| Synonyms | 6-Aminouracil; 6-Amino-2,4(1H,3H)-pyrimidinedione |
| Appearance | White to off-white powder |
| Melting Point | >300°C (decomposes) |
| Solubility | Slightly soluble in water |
| Smiles | C1=C(NC(=O)NC1=O)N |
As an accredited 6-Aminouracil factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | 6-Aminouracil is securely packaged in a 25g amber glass bottle, featuring a tamper-evident seal and clear labeling for safety. |
| Shipping | 6-Aminouracil is typically shipped in tightly sealed containers to prevent moisture and contamination. It is transported as a non-hazardous chemical under standard conditions, avoiding excessive heat and direct sunlight. All packaging complies with regulatory guidelines, ensuring product integrity and safe delivery during transit. Shipping documentation accompanies each shipment for traceability. |
| Storage | 6-Aminouracil should be stored in a tightly sealed container, away from direct sunlight, heat, and moisture. Keep it at room temperature, ideally between 15–25°C (59–77°F). Store in a cool, dry, and well-ventilated area, segregated from incompatible substances such as strong oxidizers and acids. Ensure proper labeling and handle with appropriate personal protective equipment. |
Applications of 6-Aminouracil in Industrial ManufacturingAs a specialized manufacturer of 6-Aminouracil, we supply industrial-grade material supporting advanced synthesis in pharmaceutical intermediates, fine chemical derivatives, specialty agrochemicals, and diagnostic reagents. Below, we outline critical downstream applications with process-focused detail for professional buyers and technical engineers. 1. Pharmaceutical Intermediate Synthesis: Antiviral Nucleoside Analogues6-Aminouracil serves as a key precursor in the synthesis of several antiviral nucleoside analogues, including compounds used in the development of anti-HIV and anti-hepatitis therapeutics. Our material integrates early within the nucleoside modification pathway, enabling targeted amination reactions under GMP compliance for active pharmaceutical ingredient (API) production. Process control focuses on impurity profiles and traceability, especially in multistep synthesis where it couples with glycosyl donors through phosphoramidite or triazole activation in high-purity environments. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Fine Chemical Derivatives: Heterocyclic Dye Synthesis6-Aminouracil supplies the foundational pyrimidine core for producing specialty dyes and chromophores in fine chemical synthesis. Manufacturers use it in controlled-step functionalization, such as electrophilic aromatic substitution and azo coupling, to build reactive dye bases for inkjet inks, fluorescence tags, and photostable pigments. Its nucleophilic amine site reacts under mild to moderate temperature with a range of substituents, ensuring consistent batch reproducibility for high-purity dye intermediates. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Agrochemical Research: Herbicide & Plant Growth Regulator PrecursorIn crop protection research, 6-Aminouracil operates as a scaffold molecule for synthesizing novel pyrimidine-structured herbicides and plant growth regulators. Formulators value its reactivity for constructing analogues with selective activity against broadleaf weeds. Synthesis typically starts at small pilot scale with structure–activity relationship (SAR) screening, progressing to kilo-lab scale under stricter environmental and residue controls. Downstream process chains emphasize trace-level monitoring to conform with agricultural safety and eco-toxicological standards. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Diagnostic and Research Reagents: Nucleic Acid Labeling Agents6-Aminouracil functions as a core substrate in the preparation of nucleotide analogues for diagnostic reagent manufacturers. Biotech companies apply it in DNA/RNA probe synthesis, where site-specific labeling is essential for PCR-based assays and in situ hybridization kits. Typically, chemists incorporate it via selective substitution using phosphoramidite chemistry, followed by conjugation with fluorescent moieties or biotin tags. Analytical QC includes purity, sequence identity, and absence of nucleobase side products. Strict adherence to molecular biology grade standards is required throughout production and shipment. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 6-Aminouracil prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Manufacturing 6-Aminouracil goes far beyond the act of mixing chemicals and bottling after a reactor cools. From selecting starting materials to packing the final crystalline product, everything must fit a purpose. Years on the floor have taught us there are no shortcuts to stability. Customers rely on a material that dissolves at the intended rate, forms the right intermediates, and never brings unexpected complications. We have watched the market for uracil derivatives grow, shifting demand from older, more variable processes to workflows centered on traceability and reliability. Every order placed with us reflects a trust we work every day to earn again.
Labs and factories usually ask for 6-Aminouracil by its chemical synonym, rarely by GCCI or CAS numbers, since its function takes priority over paperwork. As a trusted manufacturer, we talk details: crystalline form, moisture content, batch reproducibility, and trace impurity profile. We always explain why these properties matter in direct, measurable ways. Handling and storage aren’t afterthoughts, and our clean room measures have grown stricter as regulatory climate changes swept over the industry. Our focus remains on what makes our customers’ results match their expectations, not just what gets certified on paper.
We control every batch of 6-Aminouracil from synthesis onward. The synthesis pathway we use reduces introduction of isocyanate-based contaminants, favoring a nucleophilic amination carried out at fixed pH and temperature. We run each production loop with stainless reactors and an isolated dry room for precipitation and drying. The physical model most often shipped is the high-purity crystalline powder, appearing as light beige to off-white. It does not clump or cake if kept under usual storage, thanks to strict dryness standards during packaging. Yield consistency matters more than theoretical purity alone. Real purity comes from finishing steps—solvent washes, filtration, and drying—rather than a claim on a label.
We use standard mesh sieves so customers who scale up to tablet compression find powder flow well within expected parameters. Water content, as measured by Karl Fischer titration, remains under 0.5%. That number is not arbitrary—it prevents loss of potency in downstream synthetic steps where even a percent more moisture can throw off reagent stoichiometry by an order of magnitude. Residual solvent and trace metals are also monitored, not just for regulatory satisfaction, but because one missed run causes more customer problems than ten good ones erase.
The research world and industry turn to 6-Aminouracil for one main reason: its unique fit as a versatile nucleobase intermediate. It lends itself to synthesizing many nucleoside analogs, which show up everywhere from antiviral compounds to agricultural screening agents. We routinely discuss with pharmaceutical developers how a small shift in impurity content can stymie scale-up. For such applications, precise and consistent starting material trumps theoretical chemical purity. Our manufacturing line minimizes batch-to-batch variation, not just to score well on a certificate of analysis, but because it directly translates to experimental reproducibility for the end user.
Sometimes, not all users communicate how things should go. Years of listening have taught us to ask the right questions. Does the downstream chemistry depend on a particular polymorph? Does the customer re-dissolve and recrystallize, or use our powder directly? Are there unique bioload requirements for biopharma applications? 6-Aminouracil can be unforgiving if not handled correctly, especially in preclinical batch extensions. We don’t shy from hard conversations about sterility, cross-contamination, or shipping during summer months. Every issue solved on our end keeps downtime out of our customer’s process.
Customers look for GMP-grade and research-grade products, sometimes for strictly regulated clinical work and sometimes for routine synthesis. We run two parallel production streams, one qualifying under tighter clean room and documentation controls. Actual differences manifest in the lot release criteria: for GMP grades, we record every manipulation, track every solvent barrel, and archive all data for regulatory audits. Research grades skip some of the paperwork and physical testing but follow the same core synthetic scheme. We retain samples from every lot produced, keeping them for periods far exceeding minimum regulatory timelines. Our documentation trails are never an afterthought—when we talk about traceability, we can pull actual data from our sample archive, not just an index in a spreadsheet.
End users in pharmaceutical development care about byproduct profile, since certain isomeric side products can propagate downstream. Over the years, we worked out changes in the synthetic route and washing steps that stably bring isomeric side products below 0.1%. Elemental analysis always falls within a narrow corridor of nitrogen and carbon content—if not, we rework or scrap the batch. A customer’s syntheses must proceed confidently, with no risk of trace side products blocking catalyst activity or fouling columns.
Too often, 5-Aminouracil and other uracil derivatives land in the same category, even though their chemistry diverges sharply. 6-Aminouracil serves as a core intermediate for pathways that require tight control of regiochemistry. In oligonucleotide and prodrug construction, a misplaced amino group ruins the whole synthetic step. Experience with mixed shipments and incoming inspection show us the risk: buying from third parties where labels get swapped has led more than one facility to costly analytical mishaps, confusing 5- with 6-aminouracil. We track every lot through our own validated analytical suite—FTIR, melting point, HPLC, and NMR data back each certificate, never just relying on generic supplier paperwork.
Unlike broad-purpose uracil sources, 6-Aminouracil responds sensitively to pH and temperature in downstream chemistry. We explain this clearly to customers at order time. The synthetic pathway we maintain minimizes exposure to acid-sensitive or alkali-sensitive decomposition, which matters if you plan to move into cGMP pharmaceutical supply. Other intermediates might tolerate less exacting handling, but even a transit temperature spike above 35°C triggers a warning on our shipping log, and we open discussions with the customer before unloading. This is a level of control market distributors can’t provide, being outside the day-to-day manufacturing workflow.
Most 6-Aminouracil we ship heads straight into pharmaceutical development, though some finds its way into specialty agricultural research and even pigment precursor work. As manufacturers, we pay attention to solvent compatibility. Many customers, especially in pharma, re-dissolve 6-Aminouracil in polar aprotic solvents prior to nucleophilic substitution. We optimize particle size for quick uptake and full dissolution within typical laboratory timelines.
Handling and weighing out the product brings potential for static charge and powder loss, so we select packaging that reduces waste, using anti-static liners without leaving residues that could mess with the downstream chemistry. The feedback loops between ourselves and regular customers continue to improve our handling: a single batch sent back because of poor solubility or excess moisture shapes how we process future lots. This takes clear, fast communication between our technical team and the customer’s application specialists.
Selling a kilogram of 6-Aminouracil means nothing unless it fits into the customer’s process smoothly. Every time a customer pauses work to call about clumping, unexpected yellow color, or solubility problems, we treat the issue as a plant-floor fix, not a call center hand-off. We keep application notes and full histories of past complaints and solutions, often updating our application guides directly from production notes or lab incident logs.
We also know customers sometimes re-purpose intermediates outside traditional guidelines. Several clients working on novel anti-cancer nucleosides explained issues with batch hydrolysis. Our synthesis team then adjusted the last-stage drying temperature by five degrees and solved the yield drop from hydrolysis. These changes often spin off process improvements across all customers, not just the first to flag it. Feedback shapes continuous improvement in our line, from how we control environmental humidity to which solvents are phased out for being a pain to recover after extraction.
Raw material selection defines the outcome, no matter how careful downstream controls may be. We use pharmaceutical-approved grade cyanuric acid and ammonium sources, which keeps heavy metal and unexpected anion content low from the beginning. Every shipment of these reagents undergoes screening on third-party, independently calibrated equipment. Lab notebook entries track each barrel, making traceability built-in rather than tacked-on.
Some may ask why this matters. The answer comes through years of seeing incoming complaints about color, off-odors, and unacceptably variable chromatography baselines—all tied to cheap or inconsistent reagents at the synthesis start. We only source from large, audited manufacturers, not spot-buyers or trading companies, and we keep backup stocks to avoid quality shifts from last-minute substitutions. Our process doesn’t chase bargain raw material that brings downstream grief.
Success in 6-Aminouracil manufacturing hangs on pH control, precise reagent addition, and aggressive monitoring of each batch’s progress. Simple errors in exotherm management during amination—missed by automation—wreck batch consistency, as we learned the hard way a decade ago when early output showed inconsistent N-content. Now we supervise every run with senior chemists present, monitoring live data rather than taking samples only at the end.
Filtration and drying protect against cross-contamination and solvent residue. Our investment in upgraded vacuum ovens, fresh filter stocks, and trace moisture sensors means our drying curves land in a reproducible window batch after batch. Staff turnover in these roles stays low, so hard-earned practical knowledge persists, avoiding the “retraining lag” that interrupts so many other manufacturers.
Packing and logistics count for as much as chemistry itself. Shippers unfamiliar with temperature and moisture sensitivity of this product breed problems downstream. We only ship using insulated containers certified for hazardous and temperature-critical materials, adding tracking loggers for clients with stricter SOPs. Agreements with logistics companies lay out storage maximums and reroute processes in case of transit interruption. Every label, bag, and drum receives quality signoff from a chemist, not a shipping clerk.
Returns are rare, but we treat each as a prompt to review every stage—from the reactor, through QC, into packaging, to final delivery. Every issue gets entered into our root cause analysis archive, and repetitive issues trigger process improvements, not just refund checks.
Regulated markets keep everyone honest, and audits reveal gaps that stay hidden otherwise. We keep our doors open to regulatory, third-party, and customer audits. Full access to batch records, deviation logs, and environmental controls is the norm, not the exception. Our facility undergoes scheduled and unscheduled inspections every year, with corrective actions posted for all staff to review and learn from.
Any customer—pharmaceutical or research—gets the right to inspect at reasonable notice. We welcome this, since it forces us to keep processes tight every day, not just when an inspection looms. We have learned to see audit findings as an ongoing improvement tool, not a box-ticking compliance routine.
Over the years, close relationships lead to tailored solutions for specific technical needs. Some researchers need specialized mesh fractions for faster dissolution kinetics, while certain API projects require packaging in inert atmospheres for stability. We partner with our customers’ technical teams, using meetings and lab visits to hammer out these details before production even begins. Real partnership means listening to the smallest application issues and shaping our process to avoid them.
As regulations change and new uses for 6-Aminouracil appear, we stay up to date by keeping open channels with industry consortia, sharing best practices and learning from others’ mistakes to keep our offering as trouble-free as possible.
Processes old and new undergo constant review. Documenting mistakes and lessons learned helps both our line workers and our R&D team refine each production run. We welcome technician suggestions, holding monthly meetings and open discussions to share daily operational feedback. Operator notes from night shift have prompted new checks, new alarms, and sometimes major investments. We track how every improvement impacts real customer feedback and make it a point to share improvements upstream and downstream.
Customer reviews and technical queries shape how we develop future offerings. Our experience as manufacturers tells us that there is always a more stable, more predictable, or better-packaged batch to be made. We treat feedback as the cornerstone of progress, moving past problems and raising our own internal bar.
6-Aminouracil serves as a key intermediate for developers looking for an edge in nucleoside chemistry and related fields. Our job as a manufacturer is to keep every batch as predictable and transparent as possible. Every lot is the result of hard-won lessons, process improvement, and a handshake-level promise that we will support our product at every stage of its use. We take responsibility for the material we make, standing ready to answer questions or track down an error. Our success rides on your success—real chemistry, real results, every time.